Миокардит при инфекции COVID-19: патогенетические механизмы, сложности диагностики (обзор)

Миокардит при инфекции COVID-19: патогенетические механизмы, сложности диагностики (обзор)

Автор: Сергеева В. А., Липатова Т. Е.

Журнал: Саратовский научно-медицинский журнал @ssmj

Рубрика: Кардиология

Статья в выпуске: 3 т.17, 2021 года.

Бесплатный доступ

В обзоре обобщена актуальная информация по воспалительному миокардиальному повреждению при инфекции COVID-19. В качестве литературных источников использованы наиболее актуальные работы 2020–2021 гг., а также более ранние источники, содержащие фундаментальные сведения соответствующей тематики; наиболее значимая информация по обсуждаемой проблеме приведена в статье (всего 50 работ). Использованы запросы: «миокардит», «миокардиальное повреждение», «COVID-19» — в поисковых системах PubMed / MedLine, eLibrary. Анализ актуальной международной литературы продемонстрировал убедительные доказательства возможного развития миокардита в рамках новой коронавирусной инфекции. Значительные сложности представляет гистологическая верификация миокардиального повреждения, ассоциированного с COVID-19, так как в условиях тяжелого течения инфекции выполнение эндомиокардиальной биопсии не всегда возможно. В связи с этим статистические данные не отражают полной информации о распространенности миокардитов, ассоциированных с COVID-19. Не окончательно прояснены все механизмы патогенеза воспалительного повреждения миокарда. Для улучшения прогноза пациентов с миокардитом при инфекции COVID-19 требуется дальнейшее изучение проблемы и выработка унифицированных подходов к диагностике и лечению

Еще

COVID-19, SARS-CoV-2, миокардит, миокардиальное повреждение, сердечно-сосудистая система.

Короткий адрес: https://sciup.org/149138157

IDR: 149138157

Список литературы Миокардит при инфекции COVID-19: патогенетические механизмы, сложности диагностики (обзор)

  • Dominguez F, Kuhl U, Pieske B, et al. Update on myocarditis and inflammatory cardiomyopathy: reemergence of endomyocardial biopsy. Rev Esp Cardiol 2016; 69: 178–87.
  • Trachtenberg BH, Hare JM. Inflammatory cardiomyopathic syndromes. Circ Res 2017; 121: 803–18.
  • Caforio AL, Pankuweit S, Arbustini, et al. Current state of knowledge on etiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 2636–48. URL: http://dx.doi.org/ 10.1093 / eurheartj / eht210
  • Official website of the Russian Society of Cardiology. URL: http://www.scardio.ru / content / Guidelines / 2020 / Clinic_rekom_Miokardit. pdf
  • Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and longterm implications. Eur Heart J 2020; 0: 1–3. URL: https://doi.org / 10.1093 / eurheartj / ehaa231
  • Chen L, Li X, Chen M, et al. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res 2020; 116: 1097–100.
  • Jafarzadeh A, Chauhan P, Saha B, et al. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life Sci 2020; 257: 118–102. URL: https://doi.org / 10.1016 / j. lfs. 2020.118102
  • Sergienko IV, Rezinkina PK. New coronavirus infection COVID-19 and cardiovascular diseases. Features of therapy. The Journal of Atherosclerosis and Dyslipidemias 2021; 2 (43): 5–23. Russian (Сергиенко И. В., Резинкина П. К. Новая коронавирусная инфекция COVID-19 и сердечно-сосудистые заболевания: особенности терапии. Атеросклероз и дислипидемии 2021; 2 (43): 5–23). DOI: 10.34687 / 2219–8202. JAD.021.02.0001.
  • Sardu C, Gambardella J, Morelli MB, et al. Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med 2020; 9 (5): 1417. DOI:10.3390 / jcm9051417.
  • Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 2020; 76: 14–20. DOI: 10.1016 / j. ejim. 2020.04.037.
  • Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, arrhythmic risk and inflammation: mind the gap. Circulation 2020; 142 (1): 7–9. DOI: 10.1161 / CIRCULATIONAHA. 120.047293.
  • Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology 2020; 17 (5): 259–60.
  • Cortegiani A, Ingoglia G, Ippolito M, et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 2020; 57: 279–83. DOI: 10.1016 / j. jcrc.2020.03.005.
  • Chinello P, Petrosillo N, Pittalis S, et al. QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient. PLoS Negl Trop Dis 2017; 11 (12): e0006034. DOI: 10.1371 / journal. pntd. 0006034.
  • Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination and pathogenesis of coronaviruses. Trends Microbiol 2016; 24: 490–502.
  • Alhogbani T. Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus. Ann Saudi Med 2016; 36: 78–80.
  • Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 2020; 22 (5): 911–5. DOI: 10.1002 / ejhf. 1828.
  • Basso C, Leone O, Rizzo S, et al. Pathological features of COVID-19 associated myocardial injury: a multicenter cardiovascular pathology study. Eur Heart J 2020; 41: 3827–35.
  • Dolhnikoff M, Ferreira Ferranti J, de Almeida Monteiro RA, et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19‑related multisystem inflammatory syndrome [published correction appears in Lancet Child Adolesc Health 2020 Oct; 4 (10): e39]. Lancet Child Adolesc Health 2020; 4 (10): 790–94. DOI: 10.1016 / S2352–4642 (20) 30257–1.
  • Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. Intensive Care Med 2020; 46: 846–48.
  • Kogan EA, Berezovskiy YuS, Blagova OV, et al. Miocarditis in patients with COVID-19 confirmed by immunohistochemical. Cardiology 2020; 60 (7): 4–10. Russian (Коган Е. А., Березовский Ю. С., Благова О. В. и др. Миокардит у пациентов с COVID-19, подтвержденный результатами иммуногистохимического исследования. Кардиология 2020; 60 (7): 4–10).
  • Escher F, Pietsch H, Aleshcheva G, et al. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail 2020; 7 (5): 2440–7. DOI: 10.1002 / ehf2.12805.
  • Lindner D, Fitzek A, Bräuninger H, et al. Association of Cardiac Infection with SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol 2020; 5 (11): 1281–5. DOI: 10.1001 / jamacardio. 2020.3551.
  • Craver R, Huber S, Sandomirsky M, et al. Fatal Eosinophilic Myocarditis in a Healthy 17‑Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus (SARSCoV-2c). Fetal and Pediatric Pathology 2020; 39 (3): 263–8. [Epubahead of print]. DOI: 10.1080 / 15513815.2020.1761491.
  • Huang C, Wang Y, Li X, et. al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020; 395 (10223): 497–506. DOI: http://doi.org / 10.1016 / s0140–6736 (20) 30183–5.
  • Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2‑mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin 2020; 35 (3): 266–71.
  • Liu B, Li M, Zhou Z, et al. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19) — induced cytokine release syndrome (CRS). J Autoimmun 2020; 111: 102452. URL: https://doi.org / 10.1016 / j. jaut. 2020.102452.
  • Tajbakhsh A, Hayat SMG, et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Review of Antiinfective Therapy 2021; 19 (3): 345–57. DOI: 10.1080 / 14787210 .2020.1822737.
  • Wenzhong L, Hualan L. COVID-19: Attacks the 1‑Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. Available at: URL: https:// chemrxiv.org. Accessed 2021 Oct 14.
  • Ramos SG, Rattis B, Ottaviani G, et al. ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients. Am J Pathol 2021; 191: 1154–64. DOI: 10.1016 / j. ajpath. 2021.04.010.
  • Driggin E, Madhavan MV, Bikdeli B et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020; 75 (18): 2352–71. DOI: 10.1016 / j. jacc. 2020.03.031.
  • Hendren NS, Drazner MH, Bozkurt B, et al. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation 2020; 141 (23): 1903–14. DOI: 10.1161 / CIRCULATIONAHA. 120.047349.
  • Kawakami R, Sakamoto A, Kawai K, et al. Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC Review Topic of the Week. J Am Coll Cardiol 2021; 77 (3): 314–25.
  • Long B, Brady WJ, Koyfman A, et al. Cardiovascular complications in COVID-19. Am J Emerg Med 2020 Jul; 38 (7): 1504–7. DOI: 10.1016 / j. ajem. 2020.04.048.
  • Sawalha K, Abozenah M, Kadado AJ, et al. Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome. Cardiovasc Revasc Med 2021 Feb; 23: 107–13. DOI: 10.1016 / j. carrev. 2020.08.028.
  • Doyen D, Moceri P, Ducreux D, Dellamonica J. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. Lancet 2020; 395 (10235): 1516. DOI: 10.1016 / S0140–6736 (20) 30912–0.
  • D’Andrea A, Di Giannuario G, Marrazzo G, et al. The role of multimodality imaging in COVID-19 patients: from diagnosis to clinical monitoring and prognosis. G Ital Cardiol 2021; 21: 345–53.
  • Esposito A, Palmisano A, Natale L et al. Cardiac magnetic resonance characterization of myocarditis-like acute cardiac syndrome in COVID-19. JACC Cardiovasc Imaging 2020; 13: 2462–5.
  • Wang D, Hu B, Hu C, et. al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus Infected Pneumonia in Wuhan, China. JAMA 2020; 323 (11): 1061. DOI: http://doi.org / 10.1001 / jama. 2020.1585.
  • Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8 (5): 475–81.
  • Guo T, Fan Y, Chen M, et al. Association of cardiovascular disease and myocardial injury with outcomes of patients hospitalized with 2019‑coronavirus disease (COVID-19). JAMA Cardiol 2020; 5 (7): 811–8.
  • Deng P, Ke Z, Ying B, et al. The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19. Clin Chim Acta 2020; 510: 186–90.
  • Zinellu A, Sotgia S, Fois AG, et al. Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression. Advances in Medical Sciences 2021; 66 (2): 304–14. DOI: https://doi.org / 10.1016 / j.advms. 2021.07.001.
  • Official website of the Russian Society of Cardiology. URL: https://www.scardio.ru / content / Guidelines / 2020 / Clinic_rekom_HSN. pdf
  • Caro-Codón J, Rey JR, Buño A et al. Characterization of NT-proBNP in a large cohort of COVID-19 patients. Eur J Heart Fail 2021; 23: 456–64. URL: https://doi.org / 10.1002 / ejhf. 2095
  • Practice of echocardiography during the COVID-19 pandemic: guidance from the Canadian Society of Echocardiography. [Internet] 2020: 1–4. URL: http://csecho.ca / wp-content / uploads / 2020 / 03 / CSE-COVID-19‑Guidance_English-1. pdf. Accessed Oct 8, 2021.
  • Pirzada A, Mokhtar AT, Moeller AD. COVID-19 and Myocarditis: What Do We Know So Far? CJC Open 2020 May 28; 2 (4): 278–85. DOI: 10.1016 / j. cjco. 2020.05.005.
  • Konopleva YuYu, Petrova EV. Heart Damage with COVID-19 (Clinical Observations). Radiology — Practice 2020; 6 (84): 61–7. Russian (Коноплева Ю. Ю., Петрова Е. В. Поражение сердца при COVID-19 (клинические наблюдения). Радиология — практика 2020; 6 (84): 61–7).
  • Goha A, Mezue K, Edwards P, et al. COVID-19 and the heart: An update for clinicians. Clin Cardiol 2020; 43 (11): 1216– 22. DOI: 10.1002 / clc. 23406.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp